TEC4Home Blood Pressure Randomized Controlled Trial
- Disease/Condition
- Hypertension
- Drug/Device/Intervention
- Home Blood Pressure Telemonitoring (HBPT) + Case Management (CM)
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- University of British Columbia
- Phase
- N/A
- Start date
- Jun 01, 2024
- End date
- Jan 01, 2027
- Enrollment
- 408 participants
Systolic blood pressure controlled
The goal of this clinical trial is to evaluate the effect of home blood pressure
 telemonitoring (HBPT) and case management (CM), relative to usual care, for improving blood
 pressure (BP) control among patients with high blood pressure discharged from the emergency
 department (ED).
 
 The main question it aims to answer is: Does telemonitoring with case management improve BP
 control, relative to usual care, for people with high blood pressure discharged from the ED?
 
 Secondary research questions will address:
 
 1. How do these interventions (telemonitoring and case management) improve medication
 adherence?
 
 2. Do these interventions reduce physician and ED visits?
 
 3. Are these interventions safe?
 
 4. How do these interventions influence patient experience?
 
 Participants in the intervention group will receive training and use of a home BP telemonitor
 with tele-transmission function for 12-months plus pharmacist case management to provide
 behavioral counseling, facilitate medication adherence, review telemonitored BP data, and
 adjust medications. The control group will receive usual care from their primary care
 physician and will receive the same home BP monitor and hypertension education.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06303206
- Type
- Device Trial
Access comprehensive clinical trial information for NCT06303206 through Pure Global AI's free database. This phase not specified trial is sponsored by University of British Columbia and is currently Not yet recruiting. The study focuses on Hypertension. Target enrollment is 408 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.